DURHAM, N.C., Jan. 21 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) chairman and CEO Chris Stern will preside over the NASDAQ Opening Bell on Friday, January 22, 2010. A...
DURHAM, N.C., Jan. 13 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC:OXBT) (BULLETIN BOARD: OXBT) announced today that the company's common stock will begin trading on the NASDAQ...
DURHAM, N.C., Jan. 13 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC:OXBT) (BULLETIN BOARD: OXBT) chairman and CEO Chris Stern outlined plans for the introduction of new products...
DURHAM, N.C., Jan. 11 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC:OXBT) (BULLETIN BOARD: OXBT) announced today that company chairman and CEO Chris Stern will present at the...
DURHAM, N.C., Jan. 8 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC:OXBT) (BULLETIN BOARD: OXBT) announced today that its common stock has been approved for listing on the NASDAQ...
Adds Lt. Gen. Ronald R. Blanck (Ret.) DURHAM, N.C., Dec. 14 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC:OXBT) (BULLETIN BOARD: OXBT) today announced the expansion of the...
DURHAM, N.C., Dec. 4 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC:OXBT) (BULLETIN BOARD: OXBT) today announced that the first patient has been enrolled in the company's Phase...
DURHAM, N.C., Nov. 30 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC:OXBT) (BULLETIN BOARD: OXBT) announced that the company has received $3 million from Vatea Fund as partial...
DURHAM, N.C., Nov. 17 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC:OXBT) (BULLETIN BOARD: OXBT) today announced that the company has begun shipping Dermacyte(TM) Oxygen...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.